WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1
Authors
Keywords
-
Journal
Journal of Extracellular Vesicles
Volume 10, Issue 4, Pages -
Publisher
Wiley
Online
2021-02-09
DOI
10.1002/jev2.12067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease
- (2020) Joanne Kurtzberg et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Assessment of ST2 for risk of death following graft-versus-host disease in the pediatric and adult age groups
- (2020) Courtney Rowan et al. BLOOD
- Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell‐derived tumor growth in vitro and in vivo
- (2020) Alessia Brossa et al. INTERNATIONAL JOURNAL OF CANCER
- Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration
- (2020) Dae Hyun Ha et al. Cells
- IL-1β enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4+IL-10+ T cell balance and regulates its adhesion, proliferation and migration via PD-L1
- (2020) Aiping Zhang et al. CELLULAR IMMUNOLOGY
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
- (2019) Mauro Poggio et al. CELL
- Mesenchymal stem cells immunomodulation: The road to IFN-γ licensing and the path ahead
- (2019) Amandda Évelin Silva- Carvalho et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Mesenchymal stem cells: Cell therapy and regeneration potential
- (2019) Christina Brown et al. Journal of Tissue Engineering and Regenerative Medicine
- A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease
- (2019) Partow Kebriaei et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation
- (2019) Marina O. Gomzikova et al. Frontiers in Immunology
- Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
- (2018) Jacques Galipeau et al. Cell Stem Cell
- Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells
- (2018) Qingdong Guan et al. CYTOTHERAPY
- Mesenchymal stromal cell exosome–enhanced regulatory T-cell production through an antigen-presenting cell–mediated pathway
- (2018) Bin Zhang et al. CYTOTHERAPY
- Exosomes originating from MSCs stimulated with TGF-β and IFN-γ promote Treg differentiation
- (2018) Qingyi Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Shedding light on the cell biology of extracellular vesicles
- (2018) Guillaume van Niel et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
- (2018) Yufang Shi et al. Nature Reviews Nephrology
- Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
- (2018) Franz L. Ricklefs et al. Science Advances
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice
- (2018) Grégory Ehx et al. Frontiers in Immunology
- A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD
- (2018) Peilong Lai et al. Journal of Hematology & Oncology
- Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80
- (2018) Kaniel Cassady et al. Frontiers in Immunology
- PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells
- (2017) Xiong Ni et al. JOURNAL OF CLINICAL INVESTIGATION
- Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
- (2017) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exosomes: Therapy delivery tools and biomarkers of diseases
- (2017) Lucio Barile et al. PHARMACOLOGY & THERAPEUTICS
- Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations
- (2017) Sumie Fujii et al. STEM CELLS
- Immunomodulatory effects of mesenchymal stromal cells-derived exosome
- (2016) Wancheng Chen et al. IMMUNOLOGIC RESEARCH
- Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality
- (2016) Asim Saha et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression
- (2016) Lindsay C. Davies et al. STEM CELLS
- Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial
- (2015) Richard T. Maziarz et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study
- (2015) Kazuo Muroi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells
- (2015) L C J te Boome et al. LEUKEMIA
- High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation
- (2014) Doris M. Ponce et al. BLOOD
- Programmed Death-1 Pathway in Host Tissues Ameliorates Th17/Th1-Mediated Experimental Chronic Graft-versus-Host Disease
- (2014) Hideaki Fujiwara et al. JOURNAL OF IMMUNOLOGY
- MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease
- (2014) L Kordelas et al. LEUKEMIA
- Mesenchymal stem cells: immune evasive, not immune privileged
- (2014) James A Ankrum et al. NATURE BIOTECHNOLOGY
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- The role of B7 family molecules in hematologic malignancy
- (2012) P. Greaves et al. BLOOD
- Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study
- (2012) J. E. Levine et al. BLOOD
- Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
- (2012) E. Eggenhofer et al. Frontiers in Immunology
- Mesenchymal stromal cell ‘licensing’: a multistep process
- (2011) M Krampera LEUKEMIA
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interaction of human PD-L1 and B7-1
- (2008) Manish J. Butte et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now